Перейти к контенту
Main image
Печать
BUFALIN 1PC X 10MG
Кат. №: 203900-10MG
Производитель: Sigma-Aldrich
Кол-во:
Фасовка:
Цена по запросу
Товар оформляется под заказ
Печать
BUFALIN 1PC X 10MG
Main image
Кат. №: 203900-10MG
Производитель: Sigma-Aldrich
Кол-во:
Фасовка:
Цена по запросу
Товар оформляется под заказ
Main image
Печать
BUFALIN 1PC X 10MG
Кат. №: 203900-10MG
Производитель: Sigma-Aldrich
Кол-во:
Фасовка:
Цена по запросу
Товар оформляется под заказ
Description General description A cardiotonic steroid isolated from Bufo species toads that potently inhibits ouabain-sensitive Na+,K+-ATPase activity. Induces apoptosis in various human cell lines such as leukemia HL60 and U937 cells by altering the expression of apoptosis-related genes. Reported to stimulate the activities of p21 activated kinase (PAK) and c-Jun Kinase (JNK) in leukemic cell lines. Induces a transient increase in the expression of Tiam1 mRNA in U937 cell lines (~100 nM). Bufalin also down-regulates gene expression of the intracellular signaling protein 14-3-3 in rat lens, probably a consequence of Na+-K+-ATPase inhibitors. Reduces the level of topoisomerase II in human leukemia cells. A cardiotonic steroid isolated from toads of Bufo species that potently inhibits ouabain-sensitive Na+,K+-ATPase activity (IC50 = 1.4 nM). Induces apoptosis in various human cell lines such as leukemia HL-60 and U937 cells by altering the expression of apoptosis-related genes. Reported to stimulate the activities of p21 activated kinase (PAK) and c-Jun Kinase (JNK) in leukemic cell lines. Induces a transient increase in the expression of Tiam1 mRNA in U937 cell lines (~100 nM). Bufalin also down-regulates gene expression of the intracellular signaling protein 14-3-3 in rat lens, probably a consequence of Na+,K+-ATPase inhibition. Reduces the level of topoisomerase II in human leukemia cells. Packaging 10 mg in Alu drum Biochem/physiol Actions Cell permeable: no Primary Target Ouabain-sensitive Na+,K+-ATPase activity Product does not compete with ATP. Reversible: no Target IC50: 1.4 nM against ouabain-sensitive Na+,K+-ATPase activity Packaging Packaged under inert gas Warning Toxicity: Highly Toxic (H) Reconstitution Following reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C. Other Notes Due to the nature of the Hazardous Materials in this shipment, additional shipping charges may be applied to your order. Certain sizes may be exempt from the additional hazardous materials shipping charges. Please contact your local sales office for more information regarding these charges. Kurosawa, M., et al. 2000. Am. J. Physiol.278, C500. Kawazoe, N., et al. 1999. Oncogene 18, 2413. McGowan, M.H., et al. 1999. J. Pharmacol. Exp. Ther. 289, 1559. Watabe, M., et al. 1998. Oncogene 16, 779. Hashimoto, S., et al. 1997. Leuk. Res. 21, 875. Morris, J.F., et al. 1997. Comp. Biochem. Physiol. A Physiol. 118, 599. Brownlee, A.A., et al. 1990. Clin. Sci.78, 169.
Quality Level
100 assay
Дорогой клиент, на сайте внедрена нейросеть для сбора информации о товаре. Это может привести к незначительным расхождениям в характеристиках продукции.
Description General description A cardiotonic steroid isolated from Bufo species toads that potently inhibits ouabain-sensitive Na+,K+-ATPase activity. Induces apoptosis in various human cell lines such as leukemia HL60 and U937 cells by altering the expression of apoptosis-related genes. Reported to stimulate the activities of p21 activated kinase (PAK) and c-Jun Kinase (JNK) in leukemic cell lines. Induces a transient increase in the expression of Tiam1 mRNA in U937 cell lines (~100 nM). Bufalin also down-regulates gene expression of the intracellular signaling protein 14-3-3 in rat lens, probably a consequence of Na+-K+-ATPase inhibitors. Reduces the level of topoisomerase II in human leukemia cells. A cardiotonic steroid isolated from toads of Bufo species that potently inhibits ouabain-sensitive Na+,K+-ATPase activity (IC50 = 1.4 nM). Induces apoptosis in various human cell lines such as leukemia HL-60 and U937 cells by altering the expression of apoptosis-related genes. Reported to stimulate the activities of p21 activated kinase (PAK) and c-Jun Kinase (JNK) in leukemic cell lines. Induces a transient increase in the expression of Tiam1 mRNA in U937 cell lines (~100 nM). Bufalin also down-regulates gene expression of the intracellular signaling protein 14-3-3 in rat lens, probably a consequence of Na+,K+-ATPase inhibition. Reduces the level of topoisomerase II in human leukemia cells. Packaging 10 mg in Alu drum Biochem/physiol Actions Cell permeable: no Primary Target Ouabain-sensitive Na+,K+-ATPase activity Product does not compete with ATP. Reversible: no Target IC50: 1.4 nM against ouabain-sensitive Na+,K+-ATPase activity Packaging Packaged under inert gas Warning Toxicity: Highly Toxic (H) Reconstitution Following reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C. Other Notes Due to the nature of the Hazardous Materials in this shipment, additional shipping charges may be applied to your order. Certain sizes may be exempt from the additional hazardous materials shipping charges. Please contact your local sales office for more information regarding these charges. Kurosawa, M., et al. 2000. Am. J. Physiol.278, C500. Kawazoe, N., et al. 1999. Oncogene 18, 2413. McGowan, M.H., et al. 1999. J. Pharmacol. Exp. Ther. 289, 1559. Watabe, M., et al. 1998. Oncogene 16, 779. Hashimoto, S., et al. 1997. Leuk. Res. 21, 875. Morris, J.F., et al. 1997. Comp. Biochem. Physiol. A Physiol. 118, 599. Brownlee, A.A., et al. 1990. Clin. Sci.78, 169.
Quality Level
100 assay
Дорогой клиент, на сайте внедрена нейросеть для сбора информации о товаре. Это может привести к незначительным расхождениям в характеристиках продукции.